Seeking Alpha

Biotech startup Agios Pharmaceuticals has filed to raise $86M in an IPO. The company has raised...

Biotech startup Agios Pharmaceuticals has filed to raise $86M in an IPO. The company has raised over a quarter of a billion dollars from VC firms and Celgene (CELG), which has invested $37.5M and made $141.2M in collaboration payments. Celgene has also committed to buying stock in the IPO. Agios has been developing a new approach to treating cancer and metabolic diseases, but has yet to start clinical trials for any of its drug candidates. (S1)
Comments (1)
  • Alp Bugra Basat
    , contributor
    Comments (50) | Send Message
     
    Why Celgene didn't buy Agios? It's more like Prosensa case. I am a fun of Agios I mean I like their science but I guess things are not going on well, unfortunately...
    11 Jun 2013, 03:13 PM Reply Like
DJIA (DIA) S&P 500 (SPY)
ETF Tools
Find the right ETFs for your portfolio:
Seeking Alpha's new ETF Hub
ETF Investment Guide:
Table of Contents | One Page Summary
Read about different ETF Asset Classes:
ETF Selector